1.Post COVID-19 syndrome and new onset diseases: a prospective observational study.
Nitin SINHA ; Mahinder Pal Singh CHAWLA ; Desh DEEPAK ; Amit SURI ; Piyush JAIN ; Ankit AGARWAL ; Manoj Kumar BHAKHAR
Singapore medical journal 2025;66(7):354-361
INTRODUCTION:
The National Institute of Health and Care Excellence (NICE) has defined the terms, 'acute coronavirus disease 2019' (COVID-19), 'ongoing symptomatic COVID-19' and 'post-COVID-19 syndrome', with the latter two described as having persistent symptoms after the onset of COVID-19 symptoms for 4-12 weeks and >12 weeks, respectively. Persistent symptoms can either be due to the after-effects of COVID-19 or new-onset diseases after acute COVID-19. All symptoms observed beyond 4 weeks after the onset of COVID-19 need not be present at the time of onset. Previous studies on persistent post-COVID-19 symptoms have not mentioned new-onset diseases after acute COVID-19, and only a select few studies have discussed such new-onset symptoms.
METHODS:
Ninety-five patients who attended the post-COVID-19 clinic completed the requisite follow-up till 16 weeks after COVID-19 symptom onset. Data was recorded on a predesigned proforma. Necessary investigations were conducted to rule out any other cause of persistent symptoms.
RESULTS:
Fatigue (62.1%), breathlessness (50.5%) and cough (27.4%) were the most common symptoms present beyond 4 weeks after the onset of COVID-19 symptoms. Forty-nine (51.57%) patients developed post-COVID-19 syndrome - their severity of symptoms (odds ratio [OR] 17.77) and longer duration of hospital stay (OR 1.095) during acute disease were significantly associated with the development of post-COVID-19 syndrome. During follow-up, 25 patients developed new-onset symptoms, such as diabetes mellitus, hypertension and idiopathic tachycardia.
CONCLUSION
Patients can have persistent symptoms, new-onset symptoms and new-onset diseases after recovery from acute COVID-19.
Humans
;
COVID-19/diagnosis*
;
Female
;
Male
;
Prospective Studies
;
Middle Aged
;
Adult
;
Fatigue/etiology*
;
Post-Acute COVID-19 Syndrome
;
SARS-CoV-2
;
Aged
;
Cough/etiology*
;
Dyspnea/etiology*
2.Meige syndrome with dyspnea as main manifestation: a report of one case and literature review.
Ting LIU ; Jinkun XU ; Jingying YE
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(10):976-979
Meige syndrome is a focal dystonic movement disorder characterized by blepharospasm and oromandibular dystonia. It is a very rare disease. Individuals affected by Meige syndrome usually experience a wide array of complex symptoms including involuntary blinking and spasms of the jaw muscle. Dyspnea is rarely mentioned, due to dystonic spasm affecting the respiratory muscles. We report a case of a 69-year-old man with Meige syndrome, with dyspnea as the main clinical manifestation. Management often involves medications, botulinum toxin injections, and surgery to alleviate symptoms and enhance function. Now we reviewed the relevant literatures and summarized the experience of diagnosis and treatment in Meige syndrome.
Humans
;
Male
;
Aged
;
Dyspnea/etiology*
;
Meige Syndrome/diagnosis*
3.A case of acute severe cryptogenic organic pneumonia with secondary hemophilia.
Qianhui ZHOU ; Youxin YAN ; Yi LIU ; Jiali XIONG ; Jun ZHOU ; Yan GAO ; Lin WANG ; Quefei CHEN
Journal of Central South University(Medical Sciences) 2023;48(6):935-940
Cryptogenic organic pneumonia (COP) refers to organic pneumonia that has not been identified a clear cause by current medical methods. A small proportion of COP can exhibit severe and progressive characteristics, while severe COP can cause systemic inflammatory storms and can be secondary to hemophilia. This article reported a case of acute severe COP secondary to hemophilia. A 67-year-old male patient was admitted to the hospital due to cough, shortness of breath, and fever. At first, he was misdiagnosed as severe pneumonia, but failed to receive anti infection treatments. Sputum pathogenetic examination and Macrogene testing of alveolar lavage fluid were performed, and no etiology was found to explain the patient's condition. The condition was gradually worsened and hemophilia occurred to explain, suggesting that acute severe COP was relevant. After receiving hormone treatment, the condition gradually relieved and the absorption of lung lesions improved. Hemophilia secondary to COP is rare, and the specific mechanism needs further study.
Male
;
Humans
;
Aged
;
Hemophilia A/complications*
;
Pneumonia/diagnosis*
;
Bronchoalveolar Lavage Fluid
;
Cough
;
Dyspnea/etiology*
4.Atypical manifestations of acute coronary syndrome - throat discomfort: a multi-center observational study.
Yanqing FANG ; Xiaoting CHENG ; Wenhui PENG ; Xueying CHEN ; Chunping TANG ; Qiusheng HUANG ; Sihai WU ; Yibo HUANG ; Fanglu CHI ; Matthew R NAUNHEIM ; Huawei LI ; Bing CHEN ; Yilai SHU
Frontiers of Medicine 2022;16(4):651-658
To present the clinical characteristics and the misdiagnosis rate of acute coronary syndrome manifested primarily as throat discomfort, we conducted a multicentric and retrospective study in the cardiology and otorhinolaryngology departments. Records of patients with primary complaint of throat discomfort, absence of chest pain at onset, and an ultimate diagnosis of acute coronary syndrome, as well as patients with pharyngitis (as controls) were collected from May 2015 to April 2016. The patients' main manifestations were compared. Logistic regression results showed that chest tightness, dyspnea, perspiring, and exertional throat symptoms were significantly associated with acute coronary syndrome, with odds ratios of 8.3 (95% CI 2.2-31.5), 10.9 (95% CI 1.8-66.9), 25.4 (95% CI 3.6-179.9), and 81.2 (95% CI 13.0-506.7). A total of 25 (56.82%) out of 44 acute coronary syndrome patients, who were first admitted to the otorhinolaryngology department, were misdiagnosed, with a 12% (3/25) mortality rate. Throat discomfort can be the principal manifestation of acute coronary syndrome. Such patients exhibit high misdiagnosis and mortality rates. Exertional throat symptoms, chest tightness, perspiring, and dyspnea were important indicators of acute coronary syndrome in patients whose main complaint was throat discomfort. The awareness of this condition will result in prompt diagnosis and reduce morbidity and mortality.
Acute Coronary Syndrome/etiology*
;
Dyspnea/etiology*
;
Humans
;
Pharyngitis/diagnosis*
;
Pharynx
;
Retrospective Studies
5.Diagnosis and treatment of interstitial lung disease: focusing on idiopathic pulmonary fibrosis
Journal of the Korean Medical Association 2020;63(3):159-168
Interstitial lung disease (ILD) is a rare condition characterized by extensive inflammation and fibrosis mainly involving the pulmonary interstitium or alveoli. Usually, patients with ILD clinically present with chronic cough and exertional dyspnea. ILD is classified into subtypes based on clinical characteristics, detailed history obtained from patients, and radiological, and/or histopathological features. The most common type of idiopathic interstitial pneumonia is idiopathic pulmonary fibrosis (IPF). IPF is a chronic progressive fibrosing ILD and is associated with poor prognosis. An exclusive diagnosis of IPF requires no known condition causing ILD and typical radiological and/or histopathological features of lung fibrosis. Fibrosis observed in this condition is attributable to repetitive epithelial injury with consequent abnormal wound healing in genetically susceptible and elderly individuals. Currently, pirfenidone and nintedanib are useful disease-modifying agents available to treat IPF. In this article, we review the concept, diagnosis, clinical course, and treatment of ILD.
Aged
;
Cough
;
Diagnosis
;
Dyspnea
;
Fibrosis
;
Humans
;
Idiopathic Interstitial Pneumonias
;
Idiopathic Pulmonary Fibrosis
;
Inflammation
;
Lung
;
Lung Diseases, Interstitial
;
Prognosis
;
Wound Healing
6.Diagnostic accuracy and temporal impact of ultrasound in patients with dyspnea admitted to the emergency department
Heba R GABER ; Mahmoud I MAHMOUD ; Jenniffer CARNELL ; Anita ROHRA ; Jeffrey WUHANTU ; Sandra WILLIAMS ; Zubaid RAFIQUE ; W Frank PEACOCK
Clinical and Experimental Emergency Medicine 2019;6(3):226-234
OBJECTIVE: Few studies have prospectively evaluated the diagnostic accuracy and temporal impact of ultrasound in the emergency department (ED) in a randomized manner. In this study, we aimed to perform a randomized, standard therapy controlled evaluation of the diagnostic accuracy and temporal impact of a standardized ultrasound strategy, versus standard care, in patients presenting to the ED with acute dyspnea.METHODS: The patients underwent a standardized ultrasound examination that was blinded to the team caring for the patient. Ultrasound results remained blinded in patients randomized to the treating team but were unblinded in the interventional cohort. Scans were performed by trained emergency physicians. The gold standard diagnosis (GSDx) was determined by two physicians blinded to the ultrasound results. The same two physicians reviewed all data >30 days after the index visit.RESULTS: Fifty-nine randomized patients were enrolled. The mean±standard deviation age was 54.4±11 years, and 37 (62%) were male. The most common GSDx was acute heart failure with reduced ejection fraction in 13 (28.3%) patients and airway diseases such as acute exacerbation of asthma or chronic obstructive pulmonary disease in 10 (21.7%). ED diagnostic accuracy, as compared to the GSDx, was 76% in the ultrasound cohort and 79% in the standard care cohort (P=0.796). Compared with the standard care cohort, the final diagnosis was obtained much faster in the ultrasound cohort (mean±standard deviation: 12±3.2 minutes vs. 270 minutes, P<0.001).CONCLUSION: A standardized ultrasound approach is equally accurate, but enables faster ED diagnosis of acute dyspnea than standard care.
Asthma
;
Cohort Studies
;
Diagnosis
;
Diagnostic Imaging
;
Dyspnea
;
Emergencies
;
Emergency Service, Hospital
;
Heart Failure
;
Humans
;
Male
;
Prospective Studies
;
Pulmonary Disease, Chronic Obstructive
;
Ultrasonography
7.Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia
Jongmin LEE ; Yong Hyun KIM ; Ji Young KANG ; Yangjin JEGAL ; So Young PARK ;
Tuberculosis and Respiratory Diseases 2019;82(4):277-284
Idiopathic nonspecific interstitial pneumonia (NSIP) is one of the varieties of idiopathic interstitial pneumonias. Diagnosis of idiopathic NSIP can be done via multidisciplinary approach in which the clinical, radiologic, and pathologic findings were discussed together and exclude other causes. Clinical manifestations include subacute or chronic dyspnea and cough that last an average of 6 months, most of which occur in non-smoking, middle-aged women. The common findings in thoracic high-resolution computed tomography in NSIP are bilateral reticular opacities, traction bronchiectasis, reduced volume of the lobes, and ground-glass opacity in the lower lungs. These lesions can involve diffuse bilateral lungs or subpleural area. Unlike usual interstitial pneumonia, honeycombing is sparse or absent. Pathology shows diffuse interstitial inflammation and fibrosis which are temporally homogeneous, namely NSIP pattern. Idiopathic NSIP is usually treated with steroid only or combination with immunosuppressive agents such as azathioprine, cyclophosphamide, cyclosporine, and mycophenolate mofetil. Prognosis of idiopathic NSIP is better than idiopathic pulmonary fibrosis. Many studies have reported a 5-year survival rate of more than 70%.
Azathioprine
;
Bronchiectasis
;
Cough
;
Cyclophosphamide
;
Cyclosporine
;
Diagnosis
;
Dyspnea
;
Female
;
Fibrosis
;
Humans
;
Idiopathic Interstitial Pneumonias
;
Idiopathic Pulmonary Fibrosis
;
Immunosuppressive Agents
;
Inflammation
;
Lung
;
Lung Diseases, Interstitial
;
Pathology
;
Prognosis
;
Survival Rate
;
Traction
8.A case of neck lipoblastoma in a pediatric patient
Jae Hyung KIM ; In Hak CHOI ; Young Chan KIM ; Seung Kuk BAEK
Korean Journal of Head and Neck Oncology 2019;35(1):25-27
Lipoblastoma is a rare benign tumor with 80–90% occurring in children less than 3 years of age and 40% occurring in children less than 1 year of age. The most common site of incidence is limb, and then trunk. Neck is the rare site of incidence. The main symptom that the patient complains about is a rapidly growing neck mass without pain. When the size of mass increases, it can cause dyspnea, Horner's syndrome. Lipoblastoma is usually diagnosed as a lipoma in the fine needle aspiration. Since it is not differentiated from lipoma, liposarcoma, and hibernating adenoma in CT and MRI, the definitive diagnosis is histologic diagnosis through surgical resection. The treatment is complete surgical resection. And recurrence rate is 9–25% due to incomplete resection. Authors report this case with a review of literatures since we experienced a case of lipoblastoma diagnosed histopathologically after surgical treatment of neck mass.
Adenoma
;
Biopsy, Fine-Needle
;
Child
;
Diagnosis
;
Dyspnea
;
Extremities
;
Horner Syndrome
;
Humans
;
Incidence
;
Lipoblastoma
;
Lipoma
;
Liposarcoma
;
Magnetic Resonance Imaging
;
Neck
;
Pediatrics
;
Recurrence
9.New Diagnostic Guidelines for Idiopathic Pulmonary Fibrosis
Byoung Soo KWON ; Jin Woo SONG
Korean Journal of Medicine 2019;94(2):173-181
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterized by worsening lung function and dyspnea. The prognosis of IPF patients is poor, as median survival is approximately 3 years. However, recently developed IPF-specific therapies have shown improved efficacies in terms of reducing lung function decline and mortality. Therefore, the early recognition and accurate diagnosis of IPF are crucial. In 2018, new guidelines for the diagnosis of IPF were published by the Fleischner Society and by the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Society (ATS/ERS/JRS/ALAT). Both guidelines emphasize the need for a thorough history taking and physical examination to exclude an alternative diagnosis, such as exposure-related or connective tissue disease. The most informative initial examination is high-resolution computed tomography, the results of which can indicate the need for bronchoalveolar lavage or surgical lung biopsy, based on a multidisciplinary discussion of the findings and the patient's clinical condition. A multidisciplinary discussion of the clinico-radiologic-pathologic findings is currently the gold standard in the diagnoisis of IPF and will allow the more effective and timely treatment of these patients.
Biopsy
;
Bronchoalveolar Lavage
;
Connective Tissue Diseases
;
Diagnosis
;
Dyspnea
;
Humans
;
Idiopathic Pulmonary Fibrosis
;
Lung
;
Lung Diseases, Interstitial
;
Mortality
;
Physical Examination
;
Prognosis
10.Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
Sang Hoon LEE ; Yoomi YEO ; Tae Hyung KIM ; Hong Lyeol LEE ; Jin Hwa LEE ; Yong Bum PARK ; Jong Sun PARK ; Yee Hyung KIM ; Jin Woo SONG ; Byung Woo JHUN ; Hyun Jung KIM ; Jinkyeong PARK ; Soo Taek UH ; Young Whan KIM ; Dong Soon KIM ; Moo Suk PARK ;
Tuberculosis and Respiratory Diseases 2019;82(2):102-117
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea. Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts' help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
Delivery of Health Care
;
Diagnosis
;
Disease Management
;
Dyspnea
;
Epidemiology
;
Humans
;
Idiopathic Pulmonary Fibrosis
;
Korea
;
Lung Diseases, Interstitial
;
Lung Transplantation
;
Prognosis
;
Risk Factors
;
Tuberculosis

Result Analysis
Print
Save
E-mail